Regeneron Pharmaceuticals Modification Agreements
9 Contracts & Agreements
- Modification No. 06 to Project Agreement, dated as of July 12, 2022, by and between the Registrant and Advanced Technology International (Filed With SEC on November 3, 2022)
- Modification No. 04 to Project Agreement, dated as of July 12, 2021, by and between the Registrant and Advanced Technology International (Filed With SEC on November 3, 2022)
- Modification No. 03 to Project Agreement, dated as of May 21, 2021, by and between the Registrant and Advanced Technology International (Filed With SEC on November 3, 2022)
- Modification No. 02 to Base Agreement, dated as of August 2, 2022, by and between Regeneron Pharmaceuticals, Inc. (the "Registrant") and Advanced Technology International (Filed With SEC on November 3, 2022)
- Modification No. 0 (Filed With SEC on August 3, 2022)
- Modification No. 5 to Project Agreement, dated as of March 22, 2022, by and between the Registrant and Advanced Technology International (Filed With SEC on May 4, 2022)
- Modification No. 1 to Base Agreement, dated as of January 26, 2022, by and between the Registrant and Advanced Technology International (Filed With SEC on May 4, 2022)
- Modification No. 02 to Project Agreement, dated as of November 17, 2020, by and between the Registrant and Advanced Technology International (Filed With SEC on February 8, 2021)
- Modification No. 01 to Project Agreement, dated as of October 13, 2020, by and between the Registrant and Advanced Technology International (Filed With SEC on February 8, 2021)